Kiran Thirukonda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kiran Thirukonda has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Elijah Roberts
Office of Student Affairs Baylor College of Medicine Houston Texas USA
2 shared publications - Maya Sela
Baylor College of Medicine Houston Texas USA
2 shared publications Abbas Rana
Michael E. DeBakey Department of Surgery Division of Abdominal Transplantation Houston Texas USA
1 shared publication- Abbas Rana
Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery Baylor College of Medicine Houston Texas USA
1 shared publication Chase Robinson
Office of Student Affairs Baylor College of Medicine Houston Texas USA
1 shared publicationDavid S. Moreno McNeill
Department of Pediatrics Division of Pediatric Pulmonology Houston Texas USA
1 shared publication
Latest Publications
- Open Access
- 6 May 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (5) , e71656
Waiting List Survival Trends in Pediatric Lung Transplantation: A National Cohort Study
Background: Advancements in pediatric lung transplantation, including support devices, the Lung Allocation Score (LAS), and the subsequent Composite Allocation Score (CAS), have led to significant improvements in survival on the waiting list. Policy changes, like the removal of the Donation Service Area in 2017, aimed to further improve outcomes, but their impact in more recent years remains unclear. Our study examines recent waiting list survival trends and key factors affecting outcomes for pediatric lung transplant candidates. Methods: Pediatric patients ( n = 535) listed for lung transplantation in the OPTN Database were categorized into four eras based on year of listing: 2014–2017 ( n = 182), 2017–2020 ( n = 174), 2020–March 2023 ( n = 134), and March 2023 onward ( n = 45). Our primary outcome was death on the waiting list. Predictors of waitlist mortality were identified with multivariable logistic regression. Kaplan‐Meier curves with a log‐rank test were used to evaluate outcomes across eras. The Fine and Gray method was used to account for competing outcomes, including transplantation and removal from the waitlist due to clinical improvement. Results: Poor functional status, ventilation at time of listing, African American ethnicity, and listing in region 1 were associated with increased waitlist mortality. One‐year survival increased from 2014–2017 to 2020–2023 ( p < 0.05). When accounting for competing risks, Fine and Gray showed a declining incidence of waitlist mortality with each successive era. Conclusion: Waiting list survival for pediatric lung transplant candidates has improved since 2014, with notable progress in the 2020–2023 era. The reasons for these improvements are likely multifactorial, and further studies are needed to evaluate their impact.
- 6 May 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (5) , e71656
Open AccessWaiting List Survival Trends in Pediatric Lung Transplantation: A National Cohort Study
Background: Advancements in pediatric lung transplantation, including support devices, the Lung Allocation Score (LAS), and the subsequent Composite Allocation Score (CAS), have led to significant improvements in survival on the waiting list. Policy changes, like the removal of the Donation Service Area in 2017, aimed to further improve outcomes, but their impact in more recent years remains unclear. Our study examines recent waiting list survival trends and key factors affecting outcomes for pediatric lung transplant candidates. Methods: Pediatric patients ( n = 535) listed for lung transplantation in the OPTN Database were categorized into four eras based on year of listing: 2014–2017 ( n = 182), 2017–2020 ( n = 174), 2020–March 2023 ( n = 134), and March 2023 onward ( n = 45). Our primary outcome was death on the waiting list. Predictors of waitlist mortality were identified with multivariable logistic regression. Kaplan‐Meier curves with a log‐rank test were used to evaluate outcomes across eras. The Fine and Gray method was used to account for competing outcomes, including transplantation and removal from the waitlist due to clinical improvement. Results: Poor functional status, ventilation at time of listing, African American ethnicity, and listing in region 1 were associated with increased waitlist mortality. One‐year survival increased from 2014–2017 to 2020–2023 ( p < 0.05). When accounting for competing risks, Fine and Gray showed a declining incidence of waitlist mortality with each successive era. Conclusion: Waiting list survival for pediatric lung transplant candidates has improved since 2014, with notable progress in the 2020–2023 era. The reasons for these improvements are likely multifactorial, and further studies are needed to evaluate their impact.
- 5 May 2026
- Published by Elsevier in Heart & Lung
- Vol. 79, 102833
Improved outcomes in adult lung transplantation: a two-decade national analysis
- 5 May 2026
- Published by Elsevier in Heart & Lung
- Vol. 79, 102833
Improved outcomes in adult lung transplantation: a two-decade national analysis